2021
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
Halatsch, M.E., Kast, R.E., Karpel-Massler, G., Mayer, B., Zolk, O., Schmitz, B., Scheuerle, A., Maier, L., Bullinger, L., Mayer-Steinacker, R., Schmidt, C., Zeiler, K., Elshaer, Z., Panther, P., Schmelzle, B., Hallmen, A., Dwucet, A., Siegelin, M.D., Westhoff, M.A., Beckers, K., Bouche, G. and Heiland, T.
Neuro-Oncology Advances 3
(1): vdab075.
7 August 2021
2020
Long-lived tumor-associated macrophages in glioma.
Georgieva, P.B., Mathivet, T., Alt, S., Giese, W., Riva, M., Balcer, M. and Gerhardt, H.
Neuro-Oncology Advances 2
(1): vdaa127.
9 November 2020
This list was generated on Sat Dec 21 14:44:40 2024 UTC.